These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 8598490

  • 1. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B, Wieder KJ, Hancock WW, Zheng XX, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1996 Jan 01; 156(1):395-404. PubMed ID: 8598490
    [Abstract] [Full Text] [Related]

  • 2. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ, Hancock WW, Schmidbauer G, Corpier CL, Wieder I, Kobzik L, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1993 Jul 15; 151(2):1158-66. PubMed ID: 8335897
    [Abstract] [Full Text] [Related]

  • 3. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW.
    Transplantation; 1994 Mar 27; 57(6):933-41. PubMed ID: 8154043
    [Abstract] [Full Text] [Related]

  • 4. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 5. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 01; 27(1):423-6. PubMed ID: 7879047
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H, Cosenza CA, Wang HK, Wu GD, Makowka L, Cramer DV.
    Transplantation; 1994 Apr 15; 57(7):1072-80. PubMed ID: 8165706
    [Abstract] [Full Text] [Related]

  • 7. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK.
    Transplantation; 1995 Apr 27; 59(8):1155-61. PubMed ID: 7732563
    [Abstract] [Full Text] [Related]

  • 8. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ, Schwartz CF, Lin H, Chen GH, Bolling SF.
    J Surg Res; 1999 Feb 27; 81(2):123-8. PubMed ID: 9927530
    [Abstract] [Full Text] [Related]

  • 9. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
    Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW.
    J Immunol; 1997 Feb 15; 158(4):1572-81. PubMed ID: 9029092
    [Abstract] [Full Text] [Related]

  • 10. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187
    [Abstract] [Full Text] [Related]

  • 11. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ, Binder J, Brown LF, de Sousa M, Van de Water L, Kupiec-Weglinski JW.
    J Immunol; 1995 Mar 15; 154(6):2949-58. PubMed ID: 7876561
    [Abstract] [Full Text] [Related]

  • 12. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G, Hancock WW, Wasowska B, Binder J, Padberg W, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 15; 27(1):427-9. PubMed ID: 7879048
    [No Abstract] [Full Text] [Related]

  • 13. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
    Thai NL, Fu F, Qian S, Sun H, Gao L, Wang SC, Demetris AJ, Woo J, Thomson AW, Duquesnoy RJ.
    Transplantation; 1995 Jan 27; 59(2):274-81. PubMed ID: 7530874
    [Abstract] [Full Text] [Related]

  • 14. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, Bishop DK.
    J Immunol; 1996 Sep 01; 157(5):1951-7. PubMed ID: 8757314
    [Abstract] [Full Text] [Related]

  • 15. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
    Binder J, Hancock WW, Watschinger B, Wasowska B, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1995 Feb 27; 59(4):590-7. PubMed ID: 7878763
    [Abstract] [Full Text] [Related]

  • 16. The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation.
    McDiarmid SV, Farmer DG, Kuniyoshi JS, Robert M, Khadavi A, Shaked A, Busuttil RW.
    Transplantation; 1994 Sep 27; 58(6):690-7. PubMed ID: 7940688
    [Abstract] [Full Text] [Related]

  • 17. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts.
    O'Connell PJ, Pacheco-Silva A, Nickerson PW, Muggia RA, Bastos M, Kelley VR, Strom TB.
    J Immunol; 1993 Feb 01; 150(3):1093-104. PubMed ID: 8423334
    [Abstract] [Full Text] [Related]

  • 18. Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
    Papp I, Wieder KJ, Sablinski T, O'Connell PJ, Milford EL, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1992 Mar 01; 148(5):1308-14. PubMed ID: 1347048
    [Abstract] [Full Text] [Related]

  • 19. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM, Lan Z, Leon-Ponte M, Duffy KR, Ge W, Liu W, Mele T, Garcia B, Wang H.
    Transplantation; 2008 Aug 15; 86(3):460-8. PubMed ID: 18698251
    [Abstract] [Full Text] [Related]

  • 20. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
    Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD.
    J Immunol; 1994 Oct 01; 153(7):3307-18. PubMed ID: 8089500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.